How Much Does Stem Cell Therapy Cost in Ireland?

Stem cell therapy, as offered by regenerative medicine clinics in Ireland, almost always means an autologous procedure. Cells are harvested from your own body, most commonly mesenchymal stem cells taken from bone marrow using a technique called BMAC, short for bone marrow aspirate concentrate, or from adipose tissue, meaning fat, usually drawn from the abdomen or flank. These cells are processed and concentrated in a centrifuge, then injected back into the damaged area, typically a joint, under imaging guidance such as ultrasound.

The cost reflects a genuinely more involved procedure than a simple injection. Harvesting stem cells requires a minor surgical step, whether that is a bone marrow aspiration from the hip or a small volume of fat removed under local anaesthetic, followed by laboratory-style processing to isolate and concentrate the cells, and then image-guided injection into the target tissue. The whole process typically takes two to four hours, compared with under an hour for a straightforward PRP injection, and it requires more specialised equipment, a controlled processing environment and a practitioner trained in the harvesting technique as well as the injection itself.

In Ireland, stem cell therapy is offered by a small number of specialist regenerative medicine clinics rather than being widely available, which also affects pricing. Clinics currently offering it are concentrated in Dublin, with additional locations in Cork, Cavan and Belfast, and most position it primarily for orthopaedic and musculoskeletal conditions such as osteoarthritis, tendon injuries and joint degeneration, rather than as a general wellness treatment.

Pricing for stem cell therapy in Ireland varies more widely than for most other regenerative treatments, largely because the procedure itself varies so much in scope. Basic regenerative procedures, typically targeting a single joint with a standard bone marrow or fat-derived preparation, generally fall between EUR 3,000 and EUR 6,000. More advanced procedures, which might involve treating multiple joints in one session, a more intensive cell processing protocol, or additional regenerative components alongside the stem cells, can run from EUR 8,000 up to EUR 15,000 or more.

This is a substantial financial commitment, and it is one of the reasons most clinics offering stem cell therapy in Ireland also offer financing, commonly through interest-free instalment plans, to make the upfront cost more manageable. Unlike PRP, which is often delivered as a course of multiple sessions, stem cell therapy is more frequently a single procedure per treated area, though some clinics recommend a follow-up session or a second harvest if the initial results are insufficient.

Before committing, ask for a complete written breakdown of what is included: the consultation and any imaging required beforehand, the harvesting procedure, the laboratory processing, the injection itself, and any follow-up appointments. Because the price range is so wide, a like-for-like comparison of exactly what each clinic includes matters more here than with almost any other treatment on this site. Prices last checked in September 2026 and will vary by clinic, so always request current pricing directly.

The most relevant recent evidence comes from a 2026 systematic review and meta-analysis published in Knee Surgery, Sports Traumatology, Arthroscopy, which pooled six randomised controlled trials covering 551 patients with knee osteoarthritis treated with autologous adipose-derived mesenchymal stromal cell injections. Compared with control groups, the treated patients showed meaningfully lower pain scores at three, six and twelve months, and lower WOMAC scores, a standard measure of osteoarthritis symptoms and function, at three and six months. Serious adverse events were rare and there was no statistically significant increase in adverse events overall.

The authors were careful to frame what this does and does not show. The trials pooled varied considerably in their comparator groups, their blinding, and the specific cell products used, and the review explicitly states that these findings support symptomatic benefit across a heterogeneous group of fat-derived stem cell products, rather than establishing the efficacy of any single standardised product. Critically, the review also states that the evidence does not establish structural disease modification, meaning there is no confirmed evidence from these trials that the treatment repairs or regenerates damaged cartilage in a way that changes the underlying course of the disease, only that patients reported meaningful improvements in pain and function for a period of time.

This distinction matters for anyone considering stem cell therapy in Ireland. The realistic, evidence-supported case for stem cell therapy in knee osteoarthritis at this point is symptomatic relief with a reasonable safety profile over the medium term, not a structural cure or a certain way to avoid eventual joint replacement in more advanced disease.

Autologous stem cell procedures, where cells from your own body are minimally manipulated and used within the same procedure, are permitted in Ireland and fall outside the strictest tier of medicine regulation that applies to manufactured pharmaceutical products. The Health Products Regulatory Authority still has oversight of the broader regulatory picture around cell and tissue-based treatments, and it has published public guidance urging caution.

The HPRA's advice for patients considering cell-based therapies is direct: providers of newer cell-based therapies are not permitted to promote them to the general public for unapproved uses, some treatments may not be properly tested and could carry risk, and patients should be wary of clinics offering a single treatment that claims to address multiple unrelated conditions, of direct-to-patient advertising on social media, and of vague or evasive answers about a clinic's location or regulatory status. The authority recommends discussing any planned treatment with your own healthcare team first and contacting the HPRA directly if you are unsure whether a specific treatment or provider is operating within the rules.

In practical terms, this means stem cell therapy in Ireland occupies a more complex regulatory position than something like PRP. It is not illegal or unavailable, but it is also not a tightly standardised, centrally approved treatment in the way a licensed medicine is. That makes the reputation, transparency and clinical governance of the specific clinic you choose considerably more important than it would be for a more conventional medical procedure.

In practice, Irish clinics offering stem cell therapy focus almost entirely on orthopaedic and musculoskeletal applications. Knee osteoarthritis is the most common indication, reflecting both patient demand and the fact that this is where the strongest trial evidence currently exists. Beyond the knee, clinics also offer stem cell injections for other joints affected by osteoarthritis, for tendon injuries such as chronic tendinopathy, and for some ligament injuries, generally as an alternative or supplement to more conservative treatments that have not provided sufficient relief.

A smaller number of clinics also offer stem cell-based treatments for hair restoration or skin rejuvenation, though the evidence base for these aesthetic applications is considerably thinner than for joint conditions, and much of what supports them comes from smaller studies rather than the kind of pooled trial evidence available for knee osteoarthritis. If you are considering stem cell therapy for anything other than an established musculoskeletal indication, it is worth asking your practitioner directly what specific evidence supports that particular use, rather than assuming the general safety and efficacy data for joints applies equally.

Stem cell therapy is not currently positioned, by reputable Irish clinics or by the evidence, as a treatment for serious systemic diseases, autoimmune conditions or degenerative diseases unrelated to joints and soft tissue. Claims of this kind, wherever they are made, should be treated with real scepticism and are part of exactly what the HPRA's public warnings are aimed at.

A stem cell procedure begins with harvesting, which differs depending on the cell source. Bone marrow aspiration typically involves a needle inserted into the hip bone under local anaesthetic to draw out a small volume of marrow, a process that takes only a few minutes but can cause some discomfort and bruising afterwards. Fat-derived procedures involve a mini-liposuction style extraction, usually from the abdomen, also under local anaesthetic.

Once harvested, the material is processed in a centrifuge or specialised device to concentrate the stem cells, which typically takes a further 20 to 30 minutes. The concentrated cells are then injected into the target joint or tissue, usually under ultrasound or fluoroscopic imaging guidance to ensure accurate placement. Including harvesting, processing and injection, the whole appointment generally takes two to four hours, and you can typically go home the same day.

Afterwards, mild soreness and bruising at both the harvest site and the injection site is common for several days, and clinics typically provide a specific rehabilitation or activity protocol to follow in the weeks that follow, since how you use the treated joint afterwards can influence outcomes. Most people return to normal daily activities within a few days, though a full return to strenuous exercise or sport is usually phased in gradually over several weeks under the practitioner's guidance.

Stem cell therapy and PRP are often mentioned together, and while they share the general aim of harnessing the body's own regenerative material, they are meaningfully different. PRP concentrates the platelets and growth factors already present in your blood, while stem cell therapy harvests and concentrates actual stem cells, which have the capacity to develop into other cell types. Stem cell therapy is generally more invasive and considerably more expensive than PRP, and the trial evidence for stem cell injections in knee osteoarthritis, while positive, is currently based on fewer and smaller studies than the PRP evidence base.

For people with mild to moderate knee osteoarthritis who have not yet tried simpler options, physiotherapy, weight management, PRP or corticosteroid injections are generally reasonable starting points before considering the higher cost and more involved procedure of stem cell therapy. Stem cell therapy tends to be considered by people who have already tried more conservative measures without sufficient relief, or who are specifically seeking to delay joint replacement surgery for as long as reasonably possible.

For advanced, severely damaged joints, joint replacement surgery remains the most reliably effective option, and stem cell therapy is not currently supported by the evidence as a substitute for surgery once a joint has deteriorated to that point. A frank conversation with an orthopaedic specialist about the actual severity of your joint damage, ideally supported by imaging, is a sensible step before spending several thousand euro on stem cell therapy.

Given the regulatory grey area involved, choosing a reputable provider matters more for stem cell therapy than for almost any other treatment covered on this site. Start by asking directly about the clinic's regulatory status, what cell source and processing method they use, and what specific evidence supports the treatment for your particular condition. A reputable clinic should answer these questions clearly and should not pressure you into a decision at your first consultation.

Be wary of any clinic that suggests stem cell therapy can address multiple unrelated health conditions, that relies heavily on direct-to-consumer social media advertising with dramatic testimonials, or that is vague about where the procedure takes place or who is performing it. These are precisely the red flags the HPRA has highlighted publicly. You can also verify a treating doctor's registration through the Medical Council of Ireland's public register before booking.

Finally, get a complete written cost breakdown before committing, including the consultation, harvesting, processing, injection and any recommended follow-up, and ask about the specific rehabilitation plan you will be given afterwards, since your own activity and adherence to that plan can genuinely affect how much benefit you get from the procedure. Gerovia's directory lists stem cell therapy providers currently operating in Dublin, Cork and Belfast.